M1
Therapeutic Areas
Genekam Biotechnology Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Human Monoclonal Antibodies for H5N1 | Influenza H5N1 Infection | Pre-clinical |
| Small Molecule for SARS-CoV-2 Vaccine Complications | Post-vaccination complications | Pre-clinical (in vitro studies planned) |
| Diagnostic Tests for SARS-CoV-2 Vaccine Complications | Early detection of vaccine/post-vaccination issues | Research |